Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Nippon Kayaku

    Client Virtual Booth

    NIPPON KAYAKU

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Nippon Kayaku
    japan Flag
    Country
    Country
    Japan
    Address
    Address
    Meiji Yasuda Seimei Building 19th and 20th Floors, 1-1
    Telephone
    Telephone
    81-3-6731-5200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nipponkayaku.co.jp/english/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    AnHeart Announces Agreement With Nippon Kayaku for Taletrectinib in Japan
    AnHeart Announces Agreement With Nippon Kayaku for Taletrectinib in Japan

    https://www.businesswire.com/news/home/20231030472427/en

    BUSINESSWIRE
    30 Oct 2023
    Share Share
    Nippon Express Singapore Receives IATA CEIV Pharma Certification
    Nippon Express Singapore Receives IATA CEIV Pharma Certification

    https://www.prnewswire.com/news-releases/nippon-express-singapore-receives-iata-ceiv-pharma-certification-for-changi-international-airport-facility-301751339.html

    PR NEWSWIRE
    21 Feb 2023
    Share Share
    Solasia, Nippon Kayaku Partner in Japan for DARINAPARSIN (SP-02)
    Solasia, Nippon Kayaku Partner in Japan for DARINAPARSIN (SP-02)

    https://www.businesswire.com/news/home/20211026005660/en

    BUSINESSWIRE
    26 Oct 2021
    Share Share
    Eiger Announces License Agreement with Nippon Kayaku to Develop Bestatin
    Eiger Announces License Agreement with Nippon Kayaku to Develop Bestatin

    http://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-announces-license-agreement-with-nippon-kayaku-to-develop-bestatin-ubenimex-for-inflammatory-diseases-involving-ltb4-300174550.html

    PR NEWS WIRE
    09 Nov 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search